September 4, 2008 - Cancer patients in Europe, and possibly worldwide, may face a longer wait for diagnostic tests and treatments as a nuclear reactor in the Netherlands that supplies medical isotopes extended its shutdown for potential safety reasons.
Nuclear Research and Consultancy Group, which operates the reactor in Petten, in northwestern Netherlands, said Wednesday it would not start up the reactor again before the end of October.
About 15 to 20 percent of Canada's medical isotopes come from overseas, including the Petten facility, according to Health Canada.